Highnoon Laboratories Limited (PSX:HINOON)
1,115.70
-12.67 (-1.12%)
At close: Nov 11, 2025
Highnoon Laboratories Market Cap
Highnoon Laboratories has a market cap or net worth of 59.11 billion as of November 11, 2025. Its market cap has increased by 43.38% in one year.
Market Cap
59.11B
Enterprise Value
57.27B
Revenue
26.61B
Ranking
n/a
PE Ratio
16.09
Stock Price
1,115.70
Market Cap Chart
Since July 1, 1996, Highnoon Laboratories's market cap has increased from 188.06M to 59.11B, an increase of 31,334.12%. That is a compound annual growth rate of 21.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 59.78B | 22.89% |
| Dec 31, 2024 | 48.65B | 81.98% |
| Dec 29, 2023 | 26.73B | 18.17% |
| Dec 30, 2022 | 22.62B | -5.37% |
| Dec 31, 2021 | 23.91B | 15.14% |
| Dec 31, 2020 | 20.76B | 22.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 128.22B |
| Abbott Laboratories (Pakistan) | 107.63B |
| The Searle Company | 64.39B |
| AGP Limited | 53.82B |
| Shifa International Hospitals | 32.24B |
| Citi Pharma | 19.04B |
| Ferozsons Laboratories | 17.43B |
| Macter International | 16.52B |